The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses

Jeanna Parsons Leigh,Emily A FitzGerald,Stephana Julia Moss,Michal S Cherak,Rebecca Brundin-Mather,Alexandra Dodds,Henry T Stelfox,Ève Dubé,Kirsten M Fiest,Donna M Halperin,Sofia B Ahmed,Shannon E MacDonald,Sharon E Straus,Terra Manca,Josh Ng Kamstra,Andrea Soo,Shelly Longmore,Shelly Kupsch,Bonnie Sept,Scott A Halperin,Emily A. FitzGerald,Michal S. Cherak,Henry T. Stelfox,Kirsten M. Fiest,Donna M. Halperin,Sofia B. Ahmed,Shannon E. MacDonald,Sharon E. Straus,Scott A. Halperin
DOI: https://doi.org/10.1080/21645515.2024.2316417
2024-02-24
Human Vaccines & Immunotherapeutics
Abstract:We sought in-depth understanding on the evolution of factors influencing COVID-19 booster dose and bivalent vaccine hesitancy in a longitudinal semi-structured interview-based qualitative study. Serial interviews were conducted between July 25th and September 1 st , 2022 (Phase I: univalent booster dose availability), and between November 21 st , 2022 and January 11 th , 2023 (Phase II: bivalent vaccine availability). Adults (≥18 years) in Canada who had received an initial primary series and had not received a COVID-19 booster dose were eligible for Phase I, and subsequently invited to participate in Phase II. Twenty-two of twenty-three (96%) participants completed interviews for both phases (45 interviews). Nearly half of participants identified as a woman ( n = 11), the median age was 37 years (interquartile range: 32–48), and most participants were employed full-time ( n = 12); no participant reported needing to vaccinate (with a primary series) for their workplace. No participant reported having received a COVID-19 booster dose at the time of their interview in Phase II. Three themes relating to the development of hesitancy toward continued vaccination against COVID-19 were identified: 1) effectiveness (frequency concerns; infection despite vaccination); 2) necessity (less threatening, low urgency, alternate protective measures); and 3) information (need for data, contradiction and confusion, lack of trust, decreased motivation). The data from interviews with individuals who had not received a COVID-19 booster dose or bivalent vaccine despite having received a primary series of COVID-19 vaccines highlights actionable targets to address vaccine hesitancy and improve public health literacy.
immunology,biotechnology & applied microbiology
What problem does this paper attempt to address?